tDCS and Emotional Eating
The Use of Transcranial Direct Current Stimulation (tDCS) to Reduce Emotional Eating in Tier 3 Obese Patients: A Randomised Controlled Feasibility Trial Protocol
1 other identifier
interventional
30
1 country
1
Brief Summary
This research investigates the feasibility of undertaking a large, randomised control trial of transcranial direct current stimulation (tDCS) as a treatment modality for managing food cravings and emotional eating. This study explores how tDCS, a non-invasive brain stimulation technique, can influence brain activity and potentially impact appetite regulation, self-control, reward processing, and other factors related to weight management. All participants will receive 6 sessions of stimulation within three weeks. the investigators aim to implement a two-day interval between intervention sessions, providing participants with a two-day rest period between sessions. This scheduling approach is intended to mitigate potential side effects and promote participants' recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2024
CompletedFirst Submitted
Initial submission to the registry
May 7, 2024
CompletedFirst Posted
Study publicly available on registry
July 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedJuly 5, 2024
March 1, 2024
11 months
May 7, 2024
June 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Response rate and number of patients who met the inclusion criteria, agreed to participate in the study, and completed the study.
Response rate and number of patients who met the inclusion criteria, agreed to participate in the study, and completed the study.
5 weeks
Feasibility of completion study questionnaire.
number of patients who met the inclusion criteria, agreed to participate in the study, and completed the study questionnaire.
5 weeks
Means and standard deviations of scores on study questionnaires.
3\. Means and standard deviations of scores on study questionnaires.
5 weeks
Dropout ratio in each group
5 weeks
Safety of the intervention will be assessed by adverse event reported by patients
5 weeks
Secondary Outcomes (10)
Body weight (Kg)
5 weeks
BMI (kg/m^2)
5 weeks
The Eating Disorder Examination Questionnaire (EDE-Q)
5 weeks
The Food Cravings Questionnaire-State (FCQ-S)
5 weeks
The Emotional Eating Scale II (EES-II)
5 weeks
- +5 more secondary outcomes
Study Arms (2)
Real stimulation
EXPERIMENTALParticipants in this arm will receive 6 sessions of real tDCS.
Sham stimulation
PLACEBO COMPARATORParticipants in this arm will receive 6 sessions of sham tDCS.
Interventions
The intervention will be applied using two sponge electrodes soaked in a saline solution. The stimulation montage will comprise left DLPFC anodal or sham stimulation. The reference (cathodal) electrode will be placed over the right supraorbital ridge, and the anodal electrode will be placed over the region corresponding to the left DLPFC (F3 of the EEG10-20 international system). The 2mA continuous current will be applied during the active stimulation condition via gradual ramps that start and stop after 30 seconds of stimulation (current ramps). For sham stimulation, the electrodes will remain in place for the whole session, but the current will only be applied for the first 36 seconds of the stimulation. Each tDCS session will last for 20 minutes.
The intervention will be applied using two sponge electrodes soaked in a saline solution. The stimulation montage will comprise left DLPFC anodal or sham stimulation. The reference (cathodal) electrode will be placed over the right supraorbital ridge, and the anodal electrode will be placed over the region corresponding to the left DLPFC (F3 of the EEG10-20 international system). For sham stimulation, the electrodes will remain in place for the whole session, but the current will only be applied for the first 36 seconds of the stimulation. Each tDCS session will last for 20 minutes.
Eligibility Criteria
You may qualify if:
- Patients with obesity in tier 3.
- Capacity to consent to participate in research.
- Adults aged 18 to 65 years old.
- A high score in the emotional eating survey (minimum of 6 score in weight loss readiness questionnaire) (this will be taken from participant's medical note by usual care staff)
You may not qualify if:
- Non-obese patients (BMI\<25).
- A history of epilepsy or other major neurological disorders
- Having pacemakers or other metal implants.
- No history of eating disorders or emotional eating.
- Pregnant patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Nottingham
Derby, Royal Derby Hospital Centre Uttoxeter Road, DE22 3DT, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2024
First Posted
July 5, 2024
Study Start
February 1, 2024
Primary Completion
December 31, 2024
Study Completion
September 30, 2025
Last Updated
July 5, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share